45.21

2.24% 0.99

After Hours: 45.21

Amphastar Pharmaceuticals Inc (AMPH)

Overview News Price History Option Chain Financials Why AMPH Down? Discussions Forecast

Amphastar Pharmaceuticals Inc stock is traded at $45.21, with a volume of 436.49K. It is up +2.24% in the last 24 hours and down -10.10% over the past month. Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Previous Close:

$44.22

Open:

$44.23

24h Volume:

436.49K

Relative Volume:

1.25

Market Cap:

$2.16B

Revenue:

$723.55M

Net Income/Loss:

$157.72M

P/E Ratio:

23.18

EPS:

1.95

Net Cash Flow:

$170.15M

1W Performance:

+2.54%

1M Performance:

-10.10%

6M Performance:

+4.51%

1Y Performance:

-20.11%

1-Day Range:

$44.23

$45.71

1-Week Range:

$43.71

$46.43

52-Week Range:

$36.56

$65.92

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name

Amphastar Pharmaceuticals Inc

Sector

Healthcare (1200)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

909-980-9484

Address

11570 SIXTH STREET, RANCHO CUCAMONGA, CA

Employee

1,761

Twitter

Next Earnings Date

2024-12-06

Latest SEC Filings

AMPH's Discussions on Twitter

Compare AMPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AMPH Amphastar Pharmaceuticals Inc	45.21	2.16B	723.55M	157.72M	170.15M	1.95
ZTS Zoetis Inc	176.74	80.59B	9.15B	2.43B	2.31B	4.92
HLN Haleon Plc Adr	9.72	44.17B	14.26B	1.55B	0	0.3327
TAK Takeda Pharmaceutical Co Adr	13.57	42.61B	30.27B	1.93B	3.45B	0.444
TEVA Teva Pharmaceutical Industries Ltd Adr	16.57	18.77B	16.77B	-959.00M	1.37B	-2.00
VTRS Viatris Inc	13.22	15.73B	15.05B	-883.30M	1.89B	1.53

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-22-24	Initiated	Wells Fargo	Equal Weight
Mar-05-24	Initiated	JP Morgan	Overweight
Nov-17-23	Initiated	BofA Securities	Neutral
Jul-25-23	Resumed	Jefferies	Buy
Oct-21-22	Resumed	Jefferies	Buy
Jul-29-22	Initiated	CapitalOne	Overweight
Jan-07-22	Upgrade	Piper Sandler	Neutral → Overweight
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-05-20	Upgrade	Northland Capital	Market Perform → Outperform
May-01-20	Initiated	Northland Capital	Outperform
Mar-13-19	Downgrade	Needham	Buy → Hold
Mar-13-19	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-10-18	Reiterated	Needham	Buy
Mar-13-18	Reiterated	Needham	Buy
Dec-01-17	Reiterated	Needham	Buy
Nov-09-17	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-27-17	Reiterated	Needham	Buy
Mar-14-17	Downgrade	Raymond James	Strong Buy → Outperform
Aug-09-16	Reiterated	Needham	Buy
May-10-16	Reiterated	Needham	Buy
Feb-19-16	Initiated	Wells Fargo	Outperform
Jun-19-15	Reiterated	Needham	Buy
Jun-03-15	Initiated	Raymond James	Strong Buy
Jul-21-14	Initiated	Needham	Buy

View All

Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News

Nov 26, 2024

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference - AccessWire

Nov 26, 2024

Amphastar Continues To Push Proprietary Portfolio With Focus On Baqsimi - Citeline

Nov 26, 2024

Algert Global LLC Takes $3.22 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 26, 2024

Nov 25, 2024

Amphastar initiated with an Equal Weight at Wells Fargo - MSN

Nov 25, 2024

Nov 24, 2024

Connor Clark & Lunn Investment Management Ltd. Sells 20,448 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 24, 2024

18,968 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Segall Bryant & Hamill LLC - MarketBeat

Nov 24, 2024

Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated at Wells Fargo & Company - Defense World

Nov 24, 2024

Nov 23, 2024

Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle By Investing.com - Investing.com South Africa

Nov 23, 2024

GSA Capital Partners LLP Invests $303,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 23, 2024

Wells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight Recommendation - MSN

Nov 23, 2024

Nov 22, 2024

Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle - Investing.com

Nov 22, 2024

Nov 21, 2024

Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016. - Marketscreener.com

Nov 21, 2024

Victory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 21, 2024

Victory Capital Management Inc. Has $10.61 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 21, 2024

Nov 19, 2024

Injectables Contraceptives Market with Promising Opportunity - openPR

Nov 19, 2024

Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 19, 2024

Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 19, 2024

Nov 16, 2024

16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat

Nov 16, 2024

Nov 13, 2024

Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com

Nov 13, 2024

Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India

Nov 13, 2024

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire

Nov 13, 2024

Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan

Nov 13, 2024